Francisco Partners IV, L.P. 13D and 13G filings for GoodRx Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-03-18 4:22 pm Sale |
2025-03-16 | 13D | GoodRx Holdings, Inc. GDRX |
Francisco Partners IV, L.P. | 60,078,184 36.000% |
-10,000,000![]() (-14.27%) |
Filing |
2024-03-08 4:26 pm Sale |
2024-03-06 | 13D | GoodRx Holdings, Inc. GDRX |
Francisco Partners IV, L.P. | 70,078,184 42.900% |
-14,622,366![]() (-17.26%) |
Filing |
2021-06-01 4:16 pm Unchanged |
2021-05-19 | 13D | GoodRx Holdings, Inc. GDRX |
Francisco Partners IV, L.P. | 84,700,550 54.900% |
0 (Unchanged) |
Filing |
2021-02-12 4:32 pm Purchase |
2020-12-31 | 13G | GoodRx Holdings, Inc. GDRX |
Francisco Partners IV, L.P. | 84,700,550 65.300% |
84,700,550![]() (New Position) |
Filing |